Table 4.
Early and long-term functional outcomes after MIPA or MITA.
| Variable | Overall Cohort |
Total Adrenalectomy |
Partial Adrenalectomy |
p |
|---|---|---|---|---|
| Trifecta | 19 (21.1%) | 10 (16.3%) | 9 (31%) | 0.312 |
| - 3-month ∆TIS ≥ 50% | 25 (27.8%) | 13 (21.3%) | 12 (41.3%) | 0.067 |
| - No CKD ≥ 2 | 80 (88.9%) | 53 (86.8%) | 27 (93.1%) | 0.813 |
| - No hypokalemia (3 months) | 76 (84.4%) | 51 (83.6%) | 25 (86.2%) | 0.837 |
| Follow-up (months, median, IQR) | 42 (27–54) | 41 (24–50) | 46 (32.7–57.5) | 0.223 |
| Hypokalemia at last follow-up (n, %) | 12 (13.3%) | 9 (14.8%) | 3 (10.3%) | 0.565 |
| Cortisol replacement at last follow-up (n, %) | 4 (6.5%) | 4 (6.5%) | - | - |
| Complete clinical success (n, %) | 54 (60%) | 33 (54%) | 21 (72.4%) | 0.097 |
| Partial clinical success (n, %) | 16 (17.7%) | 14 (23%) | 2 (6.8%) | 0.136 |
| Absent clinical success (n, %) | 20 (22.3%) | 14 (23%) | 6 (20.7%) | 0.136 |
| Complete biochemical success (n, %) | 75 (83.3%) | 50 (81.9%) | 25 (86.2%) | 0.918 |
| Partial biochemical success (n, %) | 11 (12.3%) | 7 (11.4%) | 4 (13.7%) | 0.918 |
| Absent biochemical success (n, %) | 4 (4.4%) | 3 (4.91%) | 1 (3.4%) | 0.918 |